CNBC April 25, 2024
Annika Kim Constantino

Key Points

– Walgreens said it will start working directly with drugmakers to bring cell and gene therapies to U.S. patients as part of a broader effort to expand its specialty pharmacy services.

– As the company moves to “transform” its specialty pharmacy services, it will open a newly licensed facility in Pittsburgh dedicated to cell and gene therapy services.

– Specialty pharmacies have become a significant player in the U.S. health system, especially as chronic diseases become more prevalent.

Walgreens on Thursday said it will start to work directly with drugmakers to bring cell and gene therapies to U.S. patients as part of a broader expansion of its specialty pharmacy services.

The company said it is launching a new...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Pharma, Pharma / Biotech
Novartis to acquire radiopharmaceutical firm Mariana Oncology for up to $1.75B
Amgen shares soar as executives outline obesity drug push
A closer look at 2023's top biopharma deals and what lies ahead
Amid buzz for Amgen's obesity drug, company sees revenue boost
Fierce Pharma Asia—Ono buys Deciphera for $2.4B; Novartis expands PeptiDream collab; WuXi Bio exits BIO 2024

Share This Article